Erratum to: Work disability and productivity loss in patients with inflammatory bowel diseases in Hungary in the era of biologics (European Journal of Health Economics DOI:10.1007/s10198-014-0603-7);Work disability and productivity loss in patients with inflammatory bowel diseases in Hungary in the era of biologics

European Journal of Health Economics

Volumn 15, Issue SUPPL. 1, 2014, Pages

  Michael, Mandel D ^a   Bálint, Anita ^b   Lovász, Barbara D ^a   Gulácsi, László ^c   Strbák, Bálint ^c   Golovics, Petra A ^a   Farkas, Klaudia ^b   Kürti, Zsuzsanna ^a   Szilágyi, Blanka K ^a   Mohás, Anna ^a   Molnár, Tamás ^b   Lakatos, Péter L ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

^c Institute of Entrepreneurship and Innovation   (Hungary)

Author keywords

Anti TNF; CD; Hungary; Productivity loss; UC; Work disability

Indexed keywords

ABSENTEEISM; ADULT; AGE; ARTHRALGIA; ARTHRITIS; ARTICLE; CONTROLLED STUDY; COST; CROHN DISEASE; DISABILITY PENSION; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; HUMAN; HUNGARY; JOB PERFORMANCE; MAJOR CLINICAL STUDY; MALE; MEDICAL LEAVE; PATIENT HISTORY OF SURGERY; PENSION; PRESENTEEISM; PRIORITY JOURNAL; PRODUCTIVITY; RELAPSE; ULCERATIVE COLITIS; WORK DISABILITY; ADOLESCENT; ANTAGONISTS AND INHIBITORS; COLITIS, ULCERATIVE; DISABLED PERSON; ECONOMICS; INSURANCE; MEDICAL AUDIT; MIDDLE AGED; QUESTIONNAIRE; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

BIOLOGICAL FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ABSENTEEISM; ADOLESCENT; ADULT; BIOLOGICAL FACTORS; COLITIS, ULCERATIVE; CROHN DISEASE; DISABLED PERSONS; FEMALE; HUMANS; HUNGARY; INSURANCE, DISABILITY; MALE; MEDICAL AUDIT; MIDDLE AGED; QUESTIONNAIRES; SICK LEAVE; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84905700372     PISSN: 16187598     EISSN: 16187601     Source Type: Journal    
DOI: 10.1007/s10198-014-0613-5     Document Type: Erratum

References (34)

1. Miheller, P., Kiss, L.S., Juhasz, M., Mandel, M., Lakatos, P.L.: Recommendations for identifying Crohn's disease patients with poor prognosis. Expert Rev. Clin. Immunol. 9(1), 65-75 (2013)
2. Kiss, L.S., Lakatos, P.L.: Natural history of ulcerative colitis: current knowledge. Curr. Drug Targets 12(10), 1390-1395 (2011)
3. Burisch, J., Jess, T., Martinato, M., Lakatos, P.L., ECCO -Epi-Com: The burden of inflammatory bowel disease in Europe. J. Crohns Colitis 7(4), 322-337 (2013)
4. Bouguen, G., Levesque, B.G., Feagan, B.G., Kavanaugh, A., Peyrin-Biroulet, L., Colombel, J.F., Hanauer, S.B., Sandborn, W.J.: Treat to target: a proposed new paradigm for the management of Crohn's disease. Clin. Gastroenterol. Hepatol. (2013). doi:10.1016/j.cgh.2013.09.006
5. Bernstein, C.N., Loftus Jr, E.V., Ng, S.C., Lakatos, P.L., Moum, B.: Hospitalisations and surgery in Crohn's disease. Gut 61(4), 622-629 (2012)
6. Boonen, A., Dagnelie, P.C., Feleus, A., Hesselink, M.A., Muris, J.W., Stockbrügger, R.W., Russel, M.G.: The impact of inflammatory bowel disease on labor force participation: results of a population sampled case-control study. Inflamm. Bowel Dis. 8, 382-389 (2002)
7. Ananthakrishnan, A.N., Weber, L.R., Knox, J.F., Skaros, S., Emmons, J., Lundeen, S., Issa, M., Otterson, M.F., Binion, D.G.: Permanent work disability in Crohn's disease. Am. J. Gastroenterol. 103(1), 154-161 (2008)
8. Bernklev, T., Jahnsen, J., Henriksen, M., Lygren, I., Aadland, E., Sauar, J., Schulz, T., Stray, N., Vatn, M., Moum, B.: Relationship between sick leave, unemployment, disability, and health-related quality of life in patients with inflammatory bowel disease. Inflamm. Bowel Dis. 12(5), 402-412 (2006)
9. Høivik, M.L., Moum, B., Solberg, I.C., Henriksen, M., Cvancarova, M., Bernklev, T., IBSEN Group: Work disability in inflammatory bowel disease patients 10 years after disease onset: results from the IBSEN Study. Gut 62 (3), 368-375 (2013)
10. van der Valk, M.E., Mangen, M.J., Leenders, M., Dijkstra, G., van Bodegraven, A.A., Fidder, H.H., de Jong, D.J., Pierik, M., van der Woude, C.J., Romberg-Camps, M.J., Clemens, C.H., Jansen, J.M., Mahmmod, N., van de Meeberg, P.C., van der Meulen-de Jong, A.E., Ponsioen, C.Y., Bolwerk, C.J., Vermeijden, J.R., Siersema, P.D., van Oijen, M.G., Oldenburg, B., on behalf of the COIN study group and the Dutch Initiative on Crohn and Colitis: Risk factors of work disability in patients with inflammatory bowel disease - a Dutch nationwide web-based survey: work disability in inflammatory bowel disease. J. Crohns Colitis (2013). doi:10.1016/j.crohns.2013.11.019
11. Siebert, U., Wurm, J., Gothe, R.M., Arvandi, M., Vavricka, S.R., von Känel, R., Begré, S., Sulz, M.C., Meyenberger, C., Sagmeister, M., Swiss, I.B.D., Cohort Study Group: Predictors of temporary and permanent work disability in patients with inflammatory bowel disease: results of the swiss inflammatory bowel disease cohort study. Inflamm. Bowel Dis. 19(4), 847-855 (2013)
12. Stjernman, H., Tysk, C., Almer, S., et al.: Unfavourable outcome for women in a study of health-related quality of life, social factors and work disability in Crohn's disease. Eur. J. Gastroenterol. Hepatol. 23, 671-679 (2011)
13. Gibson, P.R., Vaizey, C., Black, C.M., Nicholls, R., Weston, A.R., Bampton, P., Sparrow, M., Lawrance, I.C., Selby, W.S., Andrews, J.M., Walsh, A.J., Hetzel, D.J., Macrae, F.A., Moore, G.T., Weltman, M.D., Leong, R.W., Fan, T.: Relationship between disease severity and quality of life and assessment of health care utilization and cost for ulcerative colitis in Australia: a cross-sectional, observational study. J. Crohns Colitis (2013). doi:10.1016/j.crohns.2013.11.017
14. Israeli, E., Graff, L.A., Clara, I., Walker, J.R., Lix, L.M., Targownik, L.E., Bernstein, C.N.: Low prevalence of disability among patients with inflammatory bowel diseases a decade after diagnosis. Clin. Gastroenterol. Hepatol. (2013). doi:10.1016/j.cgh.2013.12.009
15. Lennard-Jones, J.E.: Classification of inflammatory bowel disease. Scand. J. Gastroenterol. 24(suppl 170), 2-6 (1989)
16. Silverberg, M.S., Satsangi, J., Ahmad, T., Arnott, I.D., Bernstein, C.N., Brant, S.R., Caprilli, R., Colombel, J.F., Gasche, C., Geboes, K., Jewell, D.P., Karban, A., Loftus Jr, E.V., Peña, A.S., Riddell, R.H., Sachar, D.B., Schreiber, S., Steinhart, A.H., Targan, S.R., Vermeire, S., Warren, B.F.: Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a working party of the 2005 Montreal world congress of gastroenterology. Can. J. Gastroenterol. 19(Suppl A), 5-36 (2005)
17. Stange, E.F., Travis, S.P.L., Vermeire, S., Beglinger, C., Kupcinkas, L., Geboes, K., Barakauskiene, A., Villanacci, V., Von Herbay, A., Warren, B.F., Gasche, C., Tilg, H., Schreiber, S.W., Schölmerich, J., Reinisch, W., European Crohn's and Colitis Organisation: European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. Gut 55(suppl 1), 11-15 (2006)
18. Best, W.R., Becktel, J.M., Singleton, J.W., Kern Jr, F.: Development of a Crohn's disease activity index: national cooperative Crohn's disease study. Gastroenterology 70, 439-444 (1976)
19. Vermiere, S., Schreiber, S., Sandborn, W.J., Dubois, C., Rutgeerts, P.: Correlation between the Crohn's disease activity and harvey-bradshaw indices in assessing Crohn's disease severity. Clin. Gastroenterol. Hepatol. 8, 357-363 (2010)
20. Schroeder, K.W., Tremaine, W.J., Ilstrup, D.M.: Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N. Engl. J. Med. 317, 1625-1629 (1987)
21. Reilly, M.C., Zbrozek, A.S., Dukes, E.M.: The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics 4(5), 353-365 (1993)
22. Reilly Associates's WPAI translations webpage (2014). http://www.reillyassociates.net/WPAI-Translations.html. Accessed 18.01.2014
23. Hungarian Central Administration of National Pension Insurance webpage (2014). http://ww.onyf.hu/index.php?module=news&action=getfile&fid= 9762&rand=51d06e367983259f36f1f0e73a25cb4b. Accessed 18.01.2014
24. Hungarian Central Administration of National Pension Insurance webpage (2014). https://www.onyf.hu/index.php?module=news&action=getfile&fid= 9763&rand=24d24e51f4056da48ae0e96edd6743b0. Accessed 18.01.2014
25. Koopmanschap, M.A., Rutten, F.F.: A practical guide for calculating indirect costs of disease. Pharmacoeconomics 10(5), 460-466 (1996)
26. Koopmanschap, M.A., Rutten, F.F., van Ineveld, B.M., van Roijen, L.: The friction cost method for measuring indirect costs of disease. J. Health Econ. 14(2), 171-189 (1995)
27. Lofland, J.H., Pizzi, L., Frick, K.D.: A review of health-related workplace productivity loss instruments. Pharmacoeconomics 22(3), 165-184 (2004)
28. Brodszky, V., Bálint, P., Géher, P., Hodinka, L., Horváth, G., Koó, É., Péntek, M., Polgár, A., Seszták, M., Szántó, S., Ujfalussy, I., Gulácsi, L.: Disease burden of psoriatic arthritis compared to rheumatoid arthritis. Hung. Exp. Rheumatol. Int. 30(2), 199-205 (2009)
29. Péntek, M., Kobelt, G., Czirják, L., Szekanecz, Z., Poór, G., Rojkovich, B., Polgár, A., Genti, G., Kiss, C.G., Brodszky, V., Májer, I., Gulácsi, L.: Costs of rheumatoid arthritis in Hungary. J. Rheumatol. 34(6), 1437 (2007)
30. Filipovic, I., Walker, D., Forster, F., Curry, A.S.: Quantifying the economic burden of productivity loss in rheumatoid arthritis. Rheumatology 50(6), 1083-1090 (2011)
31. Puolakka, K., Kautiainen, H., Pekurinen, M., Möttönen, T., Hannonen, P., Korpela, M., Hakala, M., Arkela-Kautiainen, M., Luukkainen, R., Leirisalo-Repo, M., FIN-RACo Trial Group: Monetary value of lost productivity over a five year follow up in early rheumatoid arthritis estimated on the basis of official register data on patients' sickness absence and gross income: experience from the FIN-RACo trial. Ann. Rheum. Dis. 65(7), 899-904 (2006)
32. Verstappen, S.M., Boonen, A., Verkleij, H., Bijlsma, J.W., Buskens, E., Jacobs, J.W., Utrecht Rheumatoid Arthritis Cohort Study Group: Productivity costs among patients with rheumatoid arthritis: the influence of methods and sources to value loss of productivity. Ann. Rheum. Dis. 64(12), 1754-1760 (2005)
33. Gulácsi, L., Orlewska, E., Péntek, M.: Health economics and health technology assessment in Central and Eastern Europe: a dose of reality. Eur. J. Health Econ. 13(5), 525-531 (2012)
34. Krol, M., Brouwer, W., Rutten, F.: Productivity costs in economic evaluations: past, present, future. Pharmacoeconomics 31(7), 537-549 (2013)